Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Meyer

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Journal of Thrombosis and Haemostasis : JTH|September 29, 2011
In vivo von Willebrand factor size heterogeneity in spite of the clinical deficiency of ADAMTS-13S F DE Meyer, U Budde, H Deckmyn, et al.
Handbook of Experimental Pharmacology|August 25, 2012
Inhibitors of the interactions between collagen and its receptors on plateletsHans Deckmyn, Simon F De Meyer, Katleen Broos, et al.
Acta Psychiatrica Scandinavica|September 1, 1993
Seasonality in severity of depression: relationships to suicide and homicide occurrenceM Maes, H Y Meltzer, E Suy, et al.
Studies in Health Technology and Informatics|April 3, 2004
The PRIDEH project: taking up privacy protection services in e-healthF De Meyer, B Claerhout, G J E De Moor
Studies in Health Technology and Informatics|October 18, 2001
Electronic signature and certification models in health careF De Meyer, G J De Moor, F H Roger France
Acta Psychiatrica Scandinavica|November 1, 1994
Synchronized annual rhythms in violent suicide rate, ambient temperature and the light-dark spanM Maes, F De Meyer, P Thompson, et al.
Cardiovascular & Hematological Disorders Drug Targets|March 12, 2009
Von Willebrand factor: drug and drug targetSimon F De Meyer, Bauke De Maeyer, Hans Deckmyn, et al.
Stroke|December 20, 2011
von Willebrand factor: an emerging target in stroke therapySimon F De Meyer, Guido Stoll, Denisa D Wagner, et al.
Experimental & Translational Stroke Medicine|September 15, 2011
Platelet glycoprotein Ibα is an important mediator of ischemic stroke in miceSimon F De Meyer, Tobias Schwarz, Daphne Schatzberg, et al.
International Journal of Medical Informatics|September 2, 1998
Determination of user requirements for the secure communication of electronic medical record informationF de Meyer, P A Lundgren, G de Moor, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Journal of Thrombosis and Haemostasis : JTH|September 29, 2011
In vivo von Willebrand factor size heterogeneity in spite of the clinical deficiency of ADAMTS-13S F DE Meyer, U Budde, H Deckmyn, et al.
Handbook of Experimental Pharmacology|August 25, 2012
Inhibitors of the interactions between collagen and its receptors on plateletsHans Deckmyn, Simon F De Meyer, Katleen Broos, et al.
Acta Psychiatrica Scandinavica|September 1, 1993
Seasonality in severity of depression: relationships to suicide and homicide occurrenceM Maes, H Y Meltzer, E Suy, et al.
Studies in Health Technology and Informatics|April 3, 2004
The PRIDEH project: taking up privacy protection services in e-healthF De Meyer, B Claerhout, G J E De Moor
Studies in Health Technology and Informatics|October 18, 2001
Electronic signature and certification models in health careF De Meyer, G J De Moor, F H Roger France
Acta Psychiatrica Scandinavica|November 1, 1994
Synchronized annual rhythms in violent suicide rate, ambient temperature and the light-dark spanM Maes, F De Meyer, P Thompson, et al.
Cardiovascular & Hematological Disorders Drug Targets|March 12, 2009
Von Willebrand factor: drug and drug targetSimon F De Meyer, Bauke De Maeyer, Hans Deckmyn, et al.
Stroke|December 20, 2011
von Willebrand factor: an emerging target in stroke therapySimon F De Meyer, Guido Stoll, Denisa D Wagner, et al.
Experimental & Translational Stroke Medicine|September 15, 2011
Platelet glycoprotein Ibα is an important mediator of ischemic stroke in miceSimon F De Meyer, Tobias Schwarz, Daphne Schatzberg, et al.
International Journal of Medical Informatics|September 2, 1998
Determination of user requirements for the secure communication of electronic medical record informationF de Meyer, P A Lundgren, G de Moor, et al.
Pageof 16